BOSTON, June 21, 2018 (GLOBE NEWSWIRE) — ClinCapture, Inc. showcases Captivate 2.0, the latest version of its Electronic Data Capture (EDC) system, at DIA (Drug Information Association) Conference 2018 in Boston, MA. The ClinCapture team will be stationed in booth #930 at the Boston Convention and Exhibition Center, where thousands of healthcare professionals will meet for four days for speaking engagements and exhibitions.
“I am excited to introduce Captivate 2.0,” says CEO Scott Weidley. “Built on the same user-friendly framework featured in applications such as Facebook, Instagram, and Netflix! With this release, I believe we will usher in the next generation of EDC.”
Alongside Captivate EDC, ClinCapture offers Medical Coding, eCOA (Clinical Outcomes Assessment) / ePRO (Patient Reported Outcomes), and Randomization, as part of the Captivate “C-Suite.” Led by ClinCapture’s Captain, the feature fighters (the company’s animated personalities) represent features highlighted in Captivate EDC, including advanced features like programmable edit checks, interactive dashboards, and Risk Based Monitoring (RBM). Other benefits include a free eCRF build tool (FreeBee Builder), free training and support, and no hidden costs. ClinCapture offers Private Cloud EDC for a fraction of the cost of other EDC systems.
Captivate EDC is HIPAA-, CFR Part 11-, and GDPR-compliant, and offers easy scalability and study-build options.
ClinCapture provides a powerful eClinical platform that enables sponsors and CROs to rapidly build and deploy studies, lower clinical trials costs, and streamline data capture processes. Offering a host of private cloud solutions, ClinCapture’s technologies help advance the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/or treatment of a wide range of diseases or medical conditions.
About Drug Information Association (DIA)
DIA is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers, and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow.
Email: [email protected]